Dr Masson is a consultant nephrologist at the Royal Free Hospital. He qualified from the University of Edinburgh Medical School in 2003 having undertaken pre-clinical studies at the University of Oxford. Dr Masson then trained in nephrology and general internal medicine at the Royal Infirmary of Edinburgh and other hospitals throughout South East Scotland.

In 2015, Dr Masson was awarded his PhD from Sydney School of Public Health, University of Sydney for his thesis “Improving outcomes for people with chronic kidney disease.”

Dr Masson has interests in clinical transplantation (including living donor assessment, long-term follow-up and low clearance transplantation) and general nephrology (including new presentations, long-term follow-up of chronic kidney disease).

He is the trust’s specialty educational lead for the renal department, and is also actively involved in clinical research.



GMC number


Peer reviewed journals
• Webster AC, Nagler E, Morton R, Masson P. Lancet seminar series: Chronic kidney disease. The Lancet. 2016;
• Masson P, Kotwal S, Kelly PJ, Craig JC, Lindley RI, Cass A, Gallagher M, Webster AC. Risk factors for stroke in patients with ESKD: a cohort study. Cerebrovascular Diseases. 2016
• O’Lone EL, Connors M, Masson P, Palmer S, Strippolli GS, Parker D, Gillespie D, Craig JC, Webster AC. Cognition in people with end-stage kidney disease treated with haemodialysis: a systematic review and meta-analysis. American Journal of Kidney Diseases. June 2016
• Masson P, Webster AC. Cochrane Commentaries: Belatacept for kidney transplant recipients. Nephrology; 2015; 20; 752-754
• Masson P, Kelly PJ, Craig JC, Lindley RI, Webster AC. Risk of stroke in patients with ESRD. Clinical Journal of the American Society of Nephrology; 2015; doi: 10.2215/CJN.12001214
• Masson P, Webster AC, Huang M, Turner R, Lindley R, Craig JC. Chronic kidney disease and risk of stroke: a systematic review and meta-analysis. Nephrology, Dialysis and Transplantation; 2015; 30(7); 1162-1169; doi: 10.1093/ndt/gfv009
• Sundaralingam P, Masson P, Bourke M. Early pre-cut sphincterotomy does not increase risk during ERCP in patients with difficult biliary access: a meta-analysis of randomized controlled trials. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association; 2015; doi; 10.1016/j.cgh.2015.0.035
• Vaidya K, Arnott C, Mech A, Masson P, Sy R, Patel S. Pulmonary vein isolation compared to rate control in patients with atrial fibrillation: a systematic review and meta-analysis. Heart, Lung and Circulation; 2015; doi; 10.1016/j.hlc.2015.02.025
• Wang, L. W., Masson, P., Turner, R. M., Lord, S. W., Baines, L. A., Craig, J. C., & Webster, A. C. (2015). Prognostic value of cardiac tests in potential kidney transplant recipients: a systematic review. Transplantation; 2015; 99(4), 731-745; doi; 10.1097/TP.0000000000000611
• Masson P, Henderson LK, Chapman JR, Craig, JC, Webster AC. Belatacept for kidney transplant recipients. Cochrane database of systematic reviews 2014; Issue 11. Art. No.:CD010699. doi: 10.1002/14651858.CD010699.pub2
• Brungs D, Chen J, Masson P, Epstein RJ. Intermittent androgen deprivation is a rational standard-of-care treatment for all stages of progressive prostate cancer: results from a systematic review and meta-analysis. Prostate cancer and Prostatic diseases; 2014; Apr 1. doi: 10.1038/pcan.2014.10
• Masson P, Duthie F, Ruster L, Kelly P, Merrifield A, Craig J, Webster A. Consistency and completeness of outcomes reported in randomized trials of primary immunosuppression in kidney transplantation. American Journal of Transplantation. 2013; 13; 2892-2901.
• Masson P, Henderson L, Craig JC, Chapman JR, Webster AC. Belatacept for kidney transplant recipients (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 8. Art. No.: CD010699. DOI: 10.1002/14651858.CD010699.
• Masson P, Webster AC. Cochrane Commentaries: Induction and maintenance treatment for lupus nephritis. Nephrology. 2013 Jan;18(1):71-2.
• Henderson LK, Masson P, Craig JC, Roberts MA, Flanc RS, Strippoli GF, Webster AC. Induction and Maintenance Treatment of Proliferative Lupus Nephritis: A Meta-Analysis of Randomized Controlled Trials. American Journal of Kidney Diseases. 2013;61(1):74-87
• Henderson L, Masson P, Craig JC, Flanc RS, Roberts MA, Strippoli GFM, Webster AC. Treatment for lupus nephritis. Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD002922. DOI: 10.1002/14651858.CD002922.pub2.
• Masson P, Metcalfe W. What I tell my patients about MRSA. British Journal of Renal Medicine 2010; Vol 15 (3); 16-18.
• Masson P, Matheson S, Webster AC, Craig JC. Meta-analyses on the prevention and treatment of urinary tract infections. Infectious Disease Clinics of North America 2009; 23(2): 355-85.
• Cross NB, Webster AC, Masson P, O’Connell PJ, Craig JC. Antihypertensive treatment for kidney transplant recipients. Cochrane Database of Systematic Reviews 2009, Issue 3. CD003598.
• Cross NB, Webster AC, Masson P, O’Connell PJ, Craig JC. Antihypertensives for kidney transplant recipients: systematic review and meta-analysis of randomised controlled trials. Transplantation 2009; 88(1):7-18.
• Masson P, Sawiers W. Case Study: An Elusive Diagnosis of Renal Sarcoidosis. Scottish Medical Journal. 2006 Mar; 51(1); 54-56.
• Cruden NL, Lawes L, Masson P, Robinson SD, Ludlam CA, Newby DE. Inhibition of thrombin activatable fibrinolysis inhibitor augments fibrinolysis in human whole blood. Journal of Thrombosis & Haemostasis. 2005 Oct; 3(10): 2351-3. PMID: 16194210
Book chapters
• Masson P, Goddard J. Renal Failure. Oxford Desktop Reference of Clinical Toxicology, Oxford University Press, December 2014; Chapter 3, p70-72; Oxford University Press.
• Matheson S, Masson P, Webster AC, Craig JC. Prophylaxis and treatment of urinary tract infections in adults. Evidence based Urology, BMJ publishing, Wiley-Blackwall, July 2010, Chapter 9, p72 – 93. ISBN: 9781405185943.

Research interests include clinical epidemiology, cohort studies, and cystematic reviews and clinical transplantation.